Aditya Puri is an Investment Partner at Xeraya Capital and was part of the founding team that led Xeraya’s carve-out from Khazanah Nasional in 2012. He has more than 20 years of experience and leadership in financing new ventures, corporate investing, and international expansion in the life sciences and technology industries.

Previously, he was a director in Khazanah Nasional’s Life Sciences group, which was responsible for Khazanah’s life sciences investments. Prior to joining Khazanah, Aditya was based in the Greater Boston area working with healthcare and cleantech startups affiliated with Harvard and MIT. He evaluated new technologies and worked with inventors at high potential startups, and consulted on growth, customer acquisition, and commercialisation strategies. He was also part of the leadership team at Yankee Group, a global technology research and consulting company, where he launched, and had full P&L responsibility for, a multimillion dollar global licensing and subscription business. He joined Yankee Group as a consultant covering Asia Pacific, and advised clients on market entry, due diligence, and investment related decisions.

At Boston Scientific, a Fortune 500 medical device manufacturer, Aditya was part of a five-member team reporting to the CFO and responsible for the company’s inorganic growth and corporate development activity. In this role he identified and closed new investment opportunities, and was instrumental in deals that resulted in significant long-term value for the company. He began his career at KPMG.

Aditya has a B.S. from the University of Southern Maine, graduating summa cum laude, and received his MBA from the MIT Sloan School of Management. He has also passed all parts of the U.S. Uniform CPA Examination.